Philders Group International and EMLab P&K Will Work With Florida Heart Group to Conduct Beta Test for Airborne Pathogens.

Share Article

Philders Group International, Inc., is pleased to announce that they will join forces with EMLab P&K/Test America, the country’s leading testing laboratory for indoor air quality in commercial settings, to run a beta test regimen for air and surface pathogens utilizing the vapor phasing of hydroxyl technology provided by Degmor Inc. The tests will take place in April 2011 at the cardiac cath lab owned and operated by the Florida Heart Group in Orlando Florida.

It is critical for health care facilities to monitor their indoor environmental hygiene for healthcare acquired infections (HAIs). Florida Heart Group already has a stellar reputation for safety, and the beta testing is another way to be proactive.

Philders Group International, Inc., is pleased to announce that they will join forces with EMLab P&K/Test America, the country’s leading testing laboratory for indoor air quality in commercial settings, to run a beta test regimen for air and surface pathogens utilizing the vapor phasing of hydroxyl technology provided by Degmor Inc. The tests will take place in April 2011 at the cardiac cath lab owned and operated by the Florida Heart Group in Orlando Florida.

Philders Group International, Inc. is a highly recognized expert consulting firm for infection control for clients around the globe. They help clients to assess risk and implement protocols for infectious disease to improve indoor environmental quality and to increase the health, safety and welfare of the patient population and workers in healthcare facilities, including hospitals, extended care facilities, and urgent care offices. Marlene Linders, President and CEO of Philders Group International, explains the purpose of the upcoming tests: “It is vitally important that health care facilities monitor their indoor environmental hygiene to reduce the incidence of healthcare acquired infections (HAIs). Florida Heart Group already has a stellar reputation for safety, and the beta testing is another way to be proactive."

Dr. Michael Berg, Director for Research and Development at EMLab P&K, wrote the Standard Operating Procedures for both pre and post testing phases. Dr. Berg holds a Ph.D. in biology and is an expert in environmental testing for molds, allergens and endotoxins; he says, “It’s my job to develop and implement tests that can be used to ascertain levels of microbes in air and surface samples. Those microbes are a leading source of healthcare acquired infections, and identification is the first step in eradication.”

William Crowe, Industrial Hygienist and President of Windermere Consulting Inc, will provide the testing services for both air and surface sampling. Additonally, Mr. Crowe will author the final report to Philders Group International.

“We are very excited about this opportunity to work with Florida Heart Group,” says Ms. Linders. “The test is a winning effort for everyone involved. At the end of the day, we expect to roll out more effective testing procedures that will ultimately lead to better indoor environmental hygiene in health care facilities.”

Philders Group International, Inc. strategically assist companies to position themselves to take advantage of innovative technologies. Their medically sensitive brand recognition provides due diligence to engineers, architects, contractors, real estate managers and others involved in health care construction.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Barbra Jeffries

Barb Jeffries

Media